Physician profile
Jennifer Joseph
NPI 1528711306
$1,399.12
in general payments reported to CMS, 2019-2025
10 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $544 · 2023: $468 · 2024: $125 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.96 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $462.52 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Alexion Pharmaceuticals, INC. | $247.91 | 2022 | |
| Medtronic, INC. | $209.17 | 2025 | Inceptiv, Synchromedii |
| Chiesi USA, INC. | $125.00 | 2024 | Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2022 | |
| Genzyme Corporation | $124.81 | 2022 | |
| Noven Therapeutics, LLC | $31.94 | 2022-2023 | Secuado |
| Spineology INC. | $29.57 | 2025 | |
| Janssen Biotech, INC. | $23.36 | 2025 | Tremfya |
| Novocure INC. | $19.84 | 2023 | Optune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.